Prediction of long-term prognosis by heteroplasmy levels of the m.3243A>G mutation in patients with the mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes syndrome-Reference-Cited by-同舟云学术

Prediction of long-term prognosis by heteroplasmy levels of the m.3243A>G mutation in patients with the mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes syndrome

Published:2016-11-21 Issue:2 Volume:24 Page:255-261
ISSN:1351-5101
Container-title:European Journal of Neurology
language:en
Short-container-title:Eur J Neurol

Author:

Fayssoil A.¹²,Laforêt P.¹³,Bougouin W.⁴⁵⁶,Jardel C.⁷⁸,Lombès A.⁵⁸,Bécane H. M.¹,Berber N.¹,Stojkovic T.¹,Béhin A.¹,Eymard B.¹³,Duboc D.¹⁵⁹,Wahbi K.¹⁵⁹

Affiliation:

1. AP-HP; Pitié-Salpêtrière Hospital; Reference Centre for Muscle Diseases Paris-Est; Myology Institute; Paris France

2. AP-HP; Raymond Poincaré Hospital; Versailles Saint-Quentin en Yvelines University; Garches France

3. Myology Institute; Pitié-Salpêtrière Hospital; Pierre et Marie Curie Paris 6 University; Paris France

4. INSERM Unit 970; Paris Cardiovascular Research Centre (PARCC); Paris France

5. Paris-Descartes; Sorbonne Paris Cité University; Paris France

6. Medical Intensive Care Unit; AP-HP, Cochin Hospital; Paris France

7. Biochemistry Department; AP-HP; Pitié-Salpêtrière Hospital; Paris France

8. INSERM U1016, CNRS UMR 8104; Institut Cochin; Paris France

9. Department of Cardiology; AP-HP; Cochin Hospital; Paris Descartes University; Paris France

Funder

Association Française contre les Myopathies